Optical News

HEIDELBERG, Germany--(BUSINESS WIRE)--Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, welcomes delegates at ARVO 2025 to experience the latest research and technological developments behind Heidelberg image quality across a wide range of applications. “We are thrilled to unveil our latest advancements at ARVO," said Dr. Sebastian Rausch, Clinical Development Manager, Investigational Technologies. “These groundbreaking technologies highlight our commi...

ROCHDALE, England--(BUSINESS WIRE)--Astoriom appoints Ryan Smith as Global Head of Sales to support company in scaling biorepository and stability storage operations....

CHICAGO--(BUSINESS WIRE)--EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on partnering with and scaling software and technology-enabled businesses. Performant’s investment marks the next step in EyeMD EMR’s growth journey, supporting...

ST. LOUIS--(BUSINESS WIRE)--EyeCare Partners will bring a strong lineup of clinical research and innovation to the upcoming annual ASCRS meeting....

GENEVA--(BUSINESS WIRE)--Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The Company announced that the Board appointed Louis E. Silverman, who served on the Company’s Board from 2014-2022, as a director, effective April 24, 2025. The Company also announced that Aimee S. Weisner, who has served as a director since 2022, has...

BERKELEY, Calif.--(BUSINESS WIRE)--Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa...

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025, and will host a conference call at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the “Investors” section of the Company’s website at www.nationalvision.com/investors. A live audio webcast of the conference c...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced it has identified the event that led to its recent voluntary recall of intraocular lenses (IOLs) on the enVista platform. Now that the cause and affected lots have been confirmed, the company will return these models to market. “We voluntarily recalled these lenses because patient safety dictates every decision...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that it will hold its Annual General Meeting on May 13, 2025, at 2:00 pm CEST at the Company’s headquarters, 74 rue du Faubourg Saint-Antoine, 75012 Paris, France. The General Meeting will also be webcast li...